Chronic cough, defined as a cough persisting for eight weeks or longer, poses a significant diagnostic and therapeutic challenge to clinicians. Despite its prevalence and impact on quality of life, the approach to diagnosing and managing chronic cough remains complex and multifaceted.
A thorough history and physical examination are the cornerstones of diagnosing chronic cough. The clinician should consider common etiologies, such as gastroesophageal reflux disease (GERD), upper airway cough syndrome (UACS), and asthma. Additionally, less common causes like bronchiectasis, non-asthmatic eosinophilic bronchitis, and lung cancer should be considered in the differential diagnosis. Pertinent investigations may include chest radiography, spirometry, and bronchoscopy, among others.
Management of chronic cough is primarily etiology-based. Empiric treatment trials for the most common causes, including GERD, UACS, and asthma, are often initiated. If the cough persists despite treatment, further diagnostic testing may be warranted. In refractory cases, referral to a pulmonologist or an otolaryngologist may be necessary. Novel therapies targeting neuronal hypersensitivity and cough hypersensitivity syndrome are emerging, offering potential future strategies for management.
Given the multifactorial nature of chronic cough, a comprehensive approach is crucial. This involves considering all potential etiologies, utilizing appropriate diagnostic tests, and tailoring treatment strategies based on the underlying cause. Patient education and reassurance also play a vital role in management.
Chronic cough is a common yet challenging clinical entity. A comprehensive, systematic approach is key to unraveling the mystery of chronic cough. By considering a broad differential diagnosis, using appropriate diagnostic tools, and tailoring treatment to the underlying cause, clinicians can effectively diagnose and manage this condition, ultimately improving patient outcomes and quality of life.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation